Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Andrew Carr


Nuffield Professor of Orthopaedics

  • Former Head of Department for NDORMS
  • Former Director of the Botnar Institute for Musculoskeletal Sciences
Andrew Carr is the Nuffield Professor of Orthopaedic Surgery at the University of Oxford and trained at Bristol, Sheffield, Oxford, Seattle and Melbourne. He established the shoulder surgery service in Oxford and is past President of the British Shoulder and Elbow Surgery Society (BESS).
His research has focussed on the development and evaluation of surgical implants. Whilst working with John Goodfellow, he defined the use of the Oxford Knee as a partial knee replacement which has been implanted in over two million people worldwide. He pioneered the importance of patients’ views in assessing the outcome of surgery and the Oxford Scores, which he co-invented and is now used globally to assess patient outcomes and direct health policy.  He has improved the infrastructure for clinical trials for orthopaedic surgery in the UK, for example, including the controversial use of placebo, or sham surgery, controls in his trials. He co-founded the Royal College of Surgeons of England Trial Unit in Oxford in 2012.
He is author of over 450 publications, including more than 25 in the Lancet and BMJ, which have been cited over 40,000 times.
He led the development of the Botnar Research Institute which now houses over 300 multidisciplinary researchers and was constructed using funds raised from charitable gifts of over £30 million. The most recent, the Marcela Botnar Wing, opened in 2021 and focusses on bioengineering and biomaterials.
He was Director of the NIHR Biomedical Research Unit in Oxford from 2008-2017 and was instrumental in the relocation of the Kennedy Institute for Rheumatology to Oxford in 2013 with an investment of over £60 million from the Kennedy Trust. 
He was a Non-Executive Director and then Divisional Director of the Nuffield Orthopaedic Centre during the formation of Oxford University Hospitals NHS Trust.  He is a fellow of the Academy of Medical Sciences and an NIHR Senior Investigator.
His awards include an honorary Doctorate of Medicine from the University of Copenhagen, the Gold Medal of the British Orthopaedic Association and the Steindler Award from the USA. He is a Nuffield Medical Trustee, Chair of the Nuffield Oxford Hospitals Fund and a Trustee of the University of Bristol.

Key publications

Recent publications

More publications